Catherine Mazzacco's most recent trade in Sight Sciences Inc was a trade of 37,492 Common Stock done . Disclosure was reported to the exchange on Sept. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | Mazzacco Catherine | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Sep 2025 | 37,492 | 41,015 | - | 0 | Common Stock | |
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,952 | 78,507 | - | 0 | Common Stock | |
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 17,366 | 47,555 | - | 0 | Common Stock | |
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 2,180 | 2,180 | - | - | Stock Option (Right to Buy) | |
| Sight Sciences Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 30,189 | 0 | - | 0 | Common Stock | |
| Krystal Biotech Inc | Catherine Mazzacco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 13,600 | 13,600 | - | - | Stock Option (Right to Buy) |